Research Article

High Lipoprotein(a) Level Is Independently Associated with Adverse Clinicopathological Features in Patients with Prostate Cancer

Table 1

Baseline characteristics of the study subjects according to the risk of PCa.

All subjects ()Low-intermediate risk ()High risk () value

Demographic characteristics
 Age (years)0.230
 BMI (kg/m2)0.639
 Hypertension ( (%))140 (37.2)19 (35.2)121 (37.6)0.764
 Diabetes mellitus ( (%))49 (13.0)10 (18.5)39 (12.1)0.273
 Coronary artery disease ( (%))56 (14.9)6 (11.1)50 (15.5)0.424
 Lipid-lowering drugs ( (%))9 (2.4)2 (3.7)7 (2.2)0.623
Lipid parameters
 TG (mmol/l)1.04 (0.76-1.39)1.07 (0.68-1.49)1.04 (0.77-1.38)0.520
 TC (mmol/l)0.634
 LDL-C (mmol/l)0.359
 HDL-C (mmol/l)0.714
 TC/HDL-C0.213
 LDL-C/HDL-C0.141
 RC (mmol/l)0.903
 Lp(a) (mg/l)216 (104-382)165 (71-334)224 (110-401)0.022
Surgery ( (%))
 Radical prostatectomy75 (19.9)26 (48.1)49 (15.2)<0.001
 Bilateral orchiectomy55 (14.4)054 (16.8)0.001

Data are expressed as (%), , or median (25th-75th percentile). The bold value indicated statistical significance. PCa = prostate cancer; BMI = body mass index; PSA = prostate-specific antigen; RC = remnant cholesterol; TC = total cholesterol; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; TG = triglycerides; Lp(a) = lipoprotein(a).